|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4895 SEK | -2.10% |
|
-1.71% | +7.23% |
| 22/05 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
| 22/05 | Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology | CI |
Active Biotech AB at the Annual General Meeting held on May 15, 2013, elected Rolf Kiessling as a new Board member.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.23% | 1.67Cr | |
| +15.20% | 12TCr | |
| +19.67% | 11TCr | |
| +18.95% | 2.6TCr | |
| -23.86% | 1.94TCr | |
| -19.03% | 1.59TCr | |
| -20.90% | 1.51TCr | |
| -46.14% | 1.51TCr | |
| +63.85% | 1.49TCr | |
| +4.49% | 1.39TCr |
ACTIVE BIOTECH AB 
